Creating meaningful change in obesity care and advocacy takes commitment, collaboration and a shared vision. This October, the Obesity Action Coalition (OAC) is proud to recognize the following companies for their support on our Corporate Council, which is critical in helping us advance our mission to build a better world for individuals affected by obesity.

Pfizer (Gold)

We’re pleased to announce that Pfizer has renewed their Corporate Council membership at the Gold level. As a global leader in biopharmaceutical innovation, Pfizer applies science and cutting-edge resources to develop therapies that improve and extend lives, working to deliver breakthroughs that transform patient outcomes.

Genentech (Silver)

This October, Genentech joins OAC’s Corporate Council at the Silver level. Known for its pioneering work in biotechnology, Genentech develops and manufactures breakthrough medicines for serious and life-threatening diseases, leading the way in transformative healthcare solutions.

KVK Tech (Bronze)

KVK Tech, a trusted name in the development of FDA-approved medications, joins OAC’s Corporate Council at the Bronze level. With a commitment to high-quality production and addressing unmet patient needs, KVK Tech is dedicated to improving access to vital medicines.

About OAC’s Corporate Council

Our Corporate partnerships are extremely important to us because we strive to collaborate with industry leaders who share our values and goals.

The OAC welcomes individuals, organizations or companies who wish to join our highest level of OAC Membership and receive maximum benefits. Our Corporate Council is an excellent way to give back to the cause and help make the world a better place for people with obesity.

To learn more about OAC’s Corporate Council, click here.